These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28447926)

  • 41. [EBV-positive central nervous system lymphoproliferative disease associated with immunosuppression after organ transplantation: Long-term remission without chemotherapy].
    Gavrilina OA; Troitskaya VV; Zvonkov EE; Parovichnikova EN; Galstyan GM; Biryukova LS; Nesterenko IV; Kovrigina AM; Bazhenov AV; Savchenko VG; Savchenko VG
    Ter Arkh; 2017; 89(7):69-75. PubMed ID: 28766544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Posttransplant Lymphoproliferative Disease and Inhibitors of Mammalian Target of Rapamycin: When a Quick Look Back Can Change the Perspective.
    Castillo-Eraso L; Melilli E; Cabre C; Manonelles A; Landeyro J; Bestard O; Cruzado JM; Martinez-Vea A
    Exp Clin Transplant; 2018 Dec; 16(6):761-764. PubMed ID: 28666406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monomorphic Epstein-Barr virus (EBV)-associated large B-cell posttransplant lymphoproliferative disorder presenting as a tongue ulcer in a pancreatic transplant patient.
    Bruce AJ; Subtil A; Rogers RS; Castro LA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):e24-8. PubMed ID: 16997090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Posttransplant lymphoma--a single-center experience of 500 liver transplantations.
    Norin S; Kimby E; Ericzon BG; Christensson B; Sander B; Söderdahl G; Hägglund H
    Med Oncol; 2004; 21(3):273-84. PubMed ID: 15456956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Posttransplant lymphoproliferative disorder in a kidney transplant recipient: a case of Epstein-Barr virus-positive primary central nervous system lymphoma.
    Ali H; Waqar SHB; Majeed M; Sehar A; Mumtaz A
    Encephalitis; 2022 Jul; 2(3):83-88. PubMed ID: 37469458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aggressive posttransplant lymphoproliferative disease in a renal transplant patient treated with alemtuzumab.
    Muzaffar M; Taj A; Ratnam S
    Am J Ther; 2010; 17(6):e230-3. PubMed ID: 19918163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful treatment of systemic and central nervous system post-transplant lymphoproliferative disorder without the use of high-dose methotrexate or radiation.
    Mahapatra S; Chin CC; Iagaru A; Heerema-McKenney A; Twist CJ
    Pediatr Blood Cancer; 2014 Nov; 61(11):2107-9. PubMed ID: 25066638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A rare presentation of a posttransplant lymphoproliferative disorder.
    Sivayoganathan S; Ariyawansa D; Ambawatte P; Galahitiyawa C; Herath C
    Kidney Int; 2018 Mar; 93(3):761. PubMed ID: 29475547
    [No Abstract]   [Full Text] [Related]  

  • 49. Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications.
    Kleinschmidt-DeMasters BK; Damek DM; Lillehei KO; Dogan A; Giannini C
    J Neuropathol Exp Neurol; 2008 Nov; 67(11):1103-11. PubMed ID: 18957891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of Posttransplant Lymphoproliferative Disorder in Pediatric Patients With a Liver Transplant.
    Aliakbarian M; Dehghani SM; Geramizadeh B; Nikeghbalian S; Kasiri K; Kazemi K; Shamsaeefar A; Bahador A; Malekhosseini SA
    Exp Clin Transplant; 2015 Oct; 13(5):426-9. PubMed ID: 25232740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary central nervous system lymphoma in a renal transplant recipient with Bardet-Biedl syndrome.
    Ersoy A; Kahvecioglu S; Bekar A; Aker S; Akdag I; Dilek K
    Transplant Proc; 2005 Dec; 37(10):4323-5. PubMed ID: 16387110
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
    Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epstein-Barr virus-associated T/NK cell-type central nervous system lymphoma which manifested as a post-transplantation lymphoproliferative disorder in a renal transplant recipient.
    Omori N; Narai H; Tanaka T; Tanaka S; Yamadori I; Ichimura K; Yoshino T; Abe K; Manabe Y
    J Neurooncol; 2008 Apr; 87(2):189-91. PubMed ID: 18058068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227.
    Glass J; Won M; Schultz CJ; Brat D; Bartlett NL; Suh JH; Werner-Wasik M; Fisher BJ; Liepman MK; Augspurger M; Bokstein F; Bovi JA; Solhjem MC; Mehta MP
    J Clin Oncol; 2016 May; 34(14):1620-5. PubMed ID: 27022122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
    Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
    Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature.
    Balci MA; Pamuk GE; Unlu E; Usta U; Pamuk ON
    Lupus; 2017 Oct; 26(11):1224-1227. PubMed ID: 28152659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Primary central nervous system lymphoma].
    Royer-Perron L; Hoang-Xuan K; Houillier C
    Rev Prat; 2016 Apr; 66(4):419-422. PubMed ID: 30512707
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Late-Onset Post-transplantation Central Nervous System Lymphoproliferative Disorder: Case Report.
    Rego Silva J; Macau RA; Oliveira Coelho H; Camelo F; Cruz P; Mateus A; Oliveira A; Oliveira C; Ramos A
    Transplant Proc; 2018 Apr; 50(3):857-860. PubMed ID: 29661453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center.
    Mamzer-Bruneel MF; Lomé C; Morelon E; Levy V; Bourquelot P; Jacobs F; Gessain A; Mac Intyre E; Brousse N; Kreis H; Hermine O
    J Clin Oncol; 2000 Nov; 18(21):3622-32. PubMed ID: 11054435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
    DeFilipp Z; Li S; El-Jawahri A; Armand P; Nayak L; Wang N; Batchelor TT; Chen YB
    Cancer; 2017 Aug; 123(16):3073-3079. PubMed ID: 28369839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.